[Prognosis in Guillain-Barre syndrome assessed by clinical and neurophysiological features]

The Guillain-Barrés' syndrome (GBS) is an acute inflammatory demyelinating polyradiculoneuropathy with a relatively low incidence and a relatively good prognosis. Patients with the axonal form of GBS often have a worse prognosis. Eleven patients who were unable to walk were analyzed clinically and with nerve conduction studies in the acute illness and at a follow-up 9-54 months. The first nerve conduction study characterized seven patients with demyelinating GBS and four with axonal GBS. At follow-up nine patients had no or minor symptoms and two had moderate symptoms. There was accordance between clinical and neurophysiological findings. Patients with axonal GBS had a worse prognosis. The incidence on the island of Fyn was 1.4 per 100,000.